Yields over 5%. P/Es under 10. Are these 2 stocks the bargains of the century?

Will these turnaround stories prove value investors’ best friends or worst nightmares?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the vast majority of investors will be cheering the recent run of good form from the UK’s main indices, value investors are undoubtedly bemoaning the lack of bargains to be found as share prices rise ever higher and valuations look increasingly stretched for many stocks.

But with bumper dividends and attractive valuations, will these investors find Debenhams (LSE: DEB) and International Personal Finance (LSE: IPF) the bargains they’ve been looking for?

Struggling department store Debenhams came up on one of my value screens as its shares currently trade at only 7.6 times trailing earnings while offering a 5.86% yielding dividend that is covered more than twice by earnings. Of course, the company’s shares are trading at five-year lows for good reason as profits fall due to rising costs, increased competition and secular changes in consumer behaviour.

The million-dollar question then is whether the company can turn things around and make today’s valuation a great entry point. There were some encouraging signs in results for the six months to March. UK like-for-like sales rose 0.4% year-on-year, driven by a strong 15% increase in online sales and a shift towards emphasising the company’s beauty and make-up offerings that really resonate with shoppers.

However, this relatively impressive performance wasn’t enough to stop UK EBITDA from falling 6% year-on-year due to higher staffing costs, increased capital expenditure from redesigning stores and a 30 basis point reduction in gross margin.

That said, the business still generates a decent amount of cash flow, has a healthy balance sheet with net debt just 0.9 times EBITDA and has plenty of room to improve margins by cutting excess stock levels and decreasing discounting. If the company can continue to increase sales at a respectable clip and the new CEO’s plan to revitalise stores pays off then Debenhams could be a decent income stock for bargain hunters who are more bullish on the future of large retailers than I.

Don’t mess with the regulators 

Subprime lender International Personal Finance is an even riskier option but with its shares priced at just 5.8 times trailing earnings and a whopping 7.2% dividend yield, bargain hunters could be missing out if they didn’t take a closer look.

The good news is that the company is profitable and can comfortably cover large dividend payouts thanks to a decent balance sheet. The bad news is that pre-tax profits fell £23.5m in 2016 to £92.6m as tighter regulations negatively impacted operations in Poland, the company’s largest market.

Unfortunately these problems look set to continue as the Polish government is considering further caps on fees charged by subprime lenders and is also disputing the company’s tax strategy. If IPF loses its appeal it could face up to £134m in payments related to the years 2008 to 2015.

With these regulatory issues looming over the company like the Sword of Damocles, its low valuation makes complete sense. So, despite a hefty dividend yield and growth prospects in several other markets these Polish problems have me steering well clear of IPF.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »